CRYSTAL KLINE: Open Payments
NPI 1295227437 · BRYAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 22 payments from 13 companies in 2025. Trend: 2023 $1,366 · 2024 $92 · 2025 $705
Food & beverage: $662Education: $43
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $213 |
| Abbott Laboratories | 2 | $108 |
| Insulet Corporation | 1 | $88 |
| Mannkind Corporation | 1 | $43 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $36 |
| Amgen Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Sequel Med Tech, LLC | 1 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
Products named: Kerendia, FREESTYLE LIBRE, Omnipod, AFREZZA, ISTURISA, OTEZLA, MOUNJARO, TWIIST.
Industry payments across OH — which companies pay providers there.
